Editorial
Office
Ms
Felicity Wright, Mr. Dietrich Rordorf, Dr. Shu-Kun Lin
Molecules/MDPI, Kandererstrasse 25,
CH-4057 Basel, Switzerland. Tel. +41 61 683 7734, Fax +41 61 302 8918
E-mail:
molecules@mdpi.org
Ms Jely He (Beijing Editorial
Office)
Guest
Editor
Dr. Eduardo Sobarzo-SánchezDepartamento
de Química Orgánica, Facultad de Farmacia, Universidad de Santiago de
Compostela, E-15782 Santiago de Compostela, Spain
Tel.: +(34) 981 56 31 00 - ext. 14936; Fax: +(34) 981 59 10 14
E-mail: e.sobarzo@usc.es
URL:
http://www.usc.es
Keywords:
medicinal chemistry, natural products,
photochemistry reactivity, aporphine and oxoaporphine,
oxoisoaporphine, coumarins
Manuscript Preparation:
Manuscripts
should be prepared according to the Instructions for Authors (
http://www.mdpi.org/molecules/publguid.htm) and
submitted before
30 June 2009
by e-mail to
molecules@mdpi.org with a copy to e.sobarzo@usc.es
and mcphee@mdpi.org. The subject title of the message
should be
"Manuscript
for Special Issue on Aporphines and Oxoaporphines".
Review
papers to be considered and published:
Research articles to be considered and published:
Manuscript ID: molecules-aporph-20080915-tw-Chen
Type of Paper: Article
Tentative Title: Liriodenine Compound Inhibits in vitro Dengue Virus Replication or Anti-dengue Viral Activity of Liriodenine Derivatives
Authors: Chung-Yi Chen
Affiliation: School of Medicine and Health Sciences, Fooyin University, Kaohsiung Hsien 831, Taiwan
E-mail: xx377@mail.fy.edu.tw
Abstract: Dengue viruses (DV)
are mosquito-borne flaviviruses that
cause a large number of human infections worldwide each year. No vaccines or
chemotherapeutics are currently available.
Therefore, the increasing number of outbreaks of dengue hemorrhagic
fever caused by DV infection brings out an urgent need to develop potent anti-DV
agents. A collection of hundreds of pure components isolated from the native
plants of Taiwan,
we found purified compounds of Michelia alba for the activities to
suppress DV replication using a stable subgenomic dengue virus replicon system
that expressed firefly luciferase reporter and neomycin phosphotransferase (Neo) genes in BHK21 cell lines. The results indicated
that the liriodenine (aporphime) compound can significantly reduce luciferase-reporter
activity in a dose dependent manner. The 50% effective concentration (EC50) was 22.0 +/- 2.0 mM and no mitrochondrial toxicity was
observed at this effective concentration. Furthermore, the liriodenine compound
exhibited a synergistic antiviral activity in combination with IFN-α in DV
replicon system, in which the antiviral response was better than IFN-αalone. Collectively,
these data suggested that this novel inhibitor could be developed for potential
treatment of DV infection through combination with other therapeutics.
Webmaster:
Dr.
Shu-Kun Lin, E-mail: molecules@mdpi.org
Last update: 23 September 2008